| [1] |
Zheng R, Zhang S, Zeng H, et al. Cancer incidence and mortality in China, 2016[J]. JNCC, 2022, 2(1): 1-9.
|
| [2] |
Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review[J]. JAMA, 2021, 325(7): 669-685.
|
| [3] |
Modest DP, Ricard I, Heinemann V, et al. Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group[J]. Ann Oncol, 2016, 27(9): 1746-1753.
|
| [4] |
Le DT, Durham JN, Smith KN, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade[J]. Science, 2017, 357(6349): 409-413.
|
| [5] |
Li Q, Wang Y, Wu S, et al. CircACC1 regulates assembly and activation of AMPK complex under metabolic stress[J]. Cell Metab, 2019, 30(1): 157-173.e157.
|
| [6] |
Dai W, Xiang W, Han L, et al. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism[J]. Cancer Commun (Lond), 2022, 42(9): 848-867.
|
| [7] |
Gong J, Lin Y, Zhang H, et al. Reprogramming of lipid metabolism in cancer-associated fibroblasts potentiates migration of colorectal cancer cells[J]. Cell Death Dis, 2020, 11(4): 267.
|
| [8] |
Bacci M, Lorito N, Smiriglia A, et al. Fat and furious: lipid metabolism in antitumoral therapy response and resistance[J]. Trends Cancer, 2021, 7(3): 198-213.
|
| [9] |
Butler LM, Perone Y, Dehairs J, et al. Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention[J]. Adv Drug Deliv Rev, 2020, 159: 245-293.
|
| [10] |
Röhrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer[J]. Nat Rev Cancer, 2016, 16(11): 732-749.
|
| [11] |
Zong L, Pi Z, Liu S, et al. Liquid extraction surface analysis nanospray electrospray ionization based lipidomics for in situ analysis of tumor cells with multidrug resistance[J]. Rapid Commun Mass Spectrom, 2018, 32(19): 1683-1692.
|
| [12] |
Harayama T, Riezman H. Understanding the diversity of membrane lipid composition[J]. Nat Rev Mol Cell Biol, 2018, 19(5): 281-296.
|
| [13] |
Pike LS, Smift AL, Croteau NJ, et al. Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells[J]. Biochim Biophys Acta, 2011, 1807(6): 726-734.
|
| [14] |
Lee EA, Angka L, Rota SG, et al. Targeting mitochondria with avocatinb induces selective leukemia cell death[J]. Cancer Res, 2015, 75(12): 2478-2488.
|
| [15] |
Shao H, Mohamed EM, Xu GG, et al. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer[J]. Oncotarget, 2016, 7(4): 3832-3846.
|
| [16] |
Holla VR, Wu H, Shi Q, et al. Nuclear orphan receptor NR4A2 modulates fatty acid oxidation pathways in colorectal cancer[J]. J Biol Chem, 2011, 286(34): 30003-30009.
|
| [17] |
Ding C, Shan Z, Li M, et al. Characterization of the fatty acid metabolism in colorectal cancer to guide clinical therapy[J]. Mol Ther Oncolytics, 2021, 20: 532-544.
|
| [18] |
Wu D, Yang Y, Hou Y, et al. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1[J]. Cancer Commun (Lond), 2022, 42(1): 37-55.
|
| [19] |
Longo N, Amat di San Filippo C, Pasquali M. Disorders of carnitine transport and the carnitine cycle[J]. Am J Med Genet C Semin Med Genet, 2006, 142c(2): 77-85.
|
| [20] |
Liu F, Li X, Yan H, et al. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer[J]. Cell Signal, 2022, 92: 110267.
|
| [21] |
Li H, Chen J, Liu J, et al. CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism[J]. Exp Cell Res, 2021, 409(1): 112892.
|
| [22] |
Voloshanenko O, Schwartz U, Kranz D, et al. β-catenin-independent regulation of Wnt target genes by RoR2 and ATF2/ATF4 in colon cancer cells[J]. Sci Rep, 2018, 8(1): 3178.
|
| [23] |
Shen C, Song YH, Xie Y, et al. Downregulation of HADH promotes gastric cancer progression via Akt signaling pathway[J]. Oncotarget, 2017, 8(44): 76279-76289.
|
| [24] |
Lan C, Wu Y, Wang N, et al. Association between ABHD1 and DOK6 polymorphisms and susceptibility to Hirschsprung disease in Southern Chinese children[J]. J Cell Mol Med, 2021, 25(20): 9609-9616.
|
| [25] |
Shayman JA, Tesmer JJG. Lysosomal phospholipase A2[J]. Biochim Biophys Acta Mol Cell Biol Lipids, 2019, 1864(6): 932-940.
|
| [26] |
Jang JE, Kim HP, Han SW, et al. NFATC3-PLA2G15 fusion transcript identified by RNA sequencing promotes tumor invasion and proliferation in colorectal cancer cell lines[J]. Cancer Res Treat, 2019, 51(1): 391-401.
|